Volume 8 Issue 61
Published - 14:00 UTC 08:00 EST 2-Mar-2006 
Next Update - 14:00 UTC 08:00 EST 3-Mar-2006

Editor: Susan K. Boyer, RN
© Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.



Chocolate milk could be key to longer, healthier life

New research from The University of Auckland's Faculty of Science aims to develop a non-pharmaceutical means to maintain muscle function and quality of life in older individuals. The good news is the answer could be as simple as taking a stroll followed by a glass of chocolate milk. more  

Anti-inflammatory drug's potentially deadly side effect found to be rare

Scientists have completed an extensive study of more than 3,000 patients who received a promising anti-inflammatory drug, natalizumab, that was linked to three cases of a serious brain infection in large clinical trials halted in early 2005. more

Joslin Diabetes Center study provides first physiological evidence that insulin is critical for blood vessel formation

For people with type 2 diabetes, the death rate from a first heart attack is two to three times the death rate of patients without the disease. Similarly, patients with diabetes and ischemic (reduced blood flow) heart disease have a much higher mortality rate than the general population. more  

Primary biliary cirrhosis more prevalent around toxic waste sites in NYC

According to a new study, exposure to toxins from hazardous waste sites may be a significant risk factor for developing primary biliary cirrhosis (PBC). Published in the March 2006 issue of Hepatology, researchers found significant clusters of the disease near Superfund toxic waste sites (SFS) and that the majority of patients in New York City who need liver transplants because of PBC, reside near SFS. more

Einstein scientists discover cause and possible treatments for hereditary movement disorder 

Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered the underlying cause of a type of ataxia, hereditary disorders characterized by poor balance, loss of posture and difficulty performing rapid coordinated movement. Their work also led to a drug that significantly improved the motor coordination in mice with ataxia--a finding that could lead to better therapies for the disease. The study appears in the March issue of Nature Neuroscience and was featured in the publication's advance online edition. more

Study suggests MPA is effective treatment for hot flashes  

Mayo Clinic researchers working with other North Central Cancer Treatment Group (NCCTG) investigators have found that a single dose of depomedroxyprogesterone acetate (MPA) more effectively reduces hot flashes than does the antidepressant venlafaxine (Effexor®). Results of the study are available online in the Journal of Clinical Oncology. more

FDA approves Emsam (Selegiline) as first drug patch for depression

This week Food and Drug Administration approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression. The once a day patch works by delivering selegiline, a monoamine oxidase inhibitor or MAOI, through the skin and into the bloodstream. At its lowest strength, Emsam can be used without the dietary restrictions that are needed for all oral MAO inhibitors that are approved for treating major depression. more


Chocolate milk. Miracle substance?